Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancer.
Cucciniello L, Blondeaux E, Bighin C, Gasparro S, Russo S, Dri A, Pugliese P, Fontana A, Cortesi E, Ferzi A, Riccardi F, Sini V, Boni L, Fabi A, Montemurro F, De Laurentiis M, Arpino G, Del Mastro L, Gerratana L, Puglisi F. Cucciniello L, et al. Among authors: gerratana l. NPJ Breast Cancer. 2024 Dec 18;10(1):105. doi: 10.1038/s41523-024-00713-8. NPJ Breast Cancer. 2024. PMID: 39695115 Free PMC article.
Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling.
Gerratana L, Davis AA, Foffano L, Reduzzi C, Rossi T, Medford A, Clifton K, Shah AN, Bucheit L, Velimirovic M, Bandini S, Dai CS, Wehbe F, Gradishar WJ, Behdad A, Ulivi P, Ma CX, Puglisi F, Bardia A, Cristofanilli M. Gerratana L, et al. Cancer Lett. 2025 Jan 28;609:217325. doi: 10.1016/j.canlet.2024.217325. Epub 2024 Nov 20. Cancer Lett. 2025. PMID: 39577685
A comprehensive luminal breast cancer patient-derived xenografts (PDX) library to capture tumor heterogeneity and explore the mechanisms of resistance to CDK4/6 inhibitors.
Segatto I, Mattevi MC, Rampioni Vinciguerra GL, Crestan N, Musco L, Favero A, Dall'Acqua A, Di Giustino G, Mungo G, D'Andrea S, Gava C, Ruggiero F, Dugo M, Gerratana L, Puglisi F, Massarut S, Bomben R, Callari M, Perin T, Baldassarre G, Belletti B. Segatto I, et al. Among authors: gerratana l. J Pathol. 2024 Dec;264(4):434-447. doi: 10.1002/path.6358. Epub 2024 Oct 25. J Pathol. 2024. PMID: 39449657
Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring.
Cecchin E, Orleni M, Gagno S, Montico M, Peruzzi E, Roncato R, Gerratana L, Corsetti S, Puglisi F, Toffoli G, Cecchin E, Posocco B. Cecchin E, et al. Among authors: gerratana l. Int J Mol Sci. 2024 Sep 27;25(19):10453. doi: 10.3390/ijms251910453. Int J Mol Sci. 2024. PMID: 39408783 Free PMC article.
Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug-gene interactions.
Peruzzi E, Posocco B, Gerratana L, Nuti M, Orleni M, Gagno S, De Mattia E, Puglisi F, Cecchin E, Toffoli G, Roncato R. Peruzzi E, et al. Among authors: gerratana l. Front Pharmacol. 2024 Sep 6;15:1420174. doi: 10.3389/fphar.2024.1420174. eCollection 2024. Front Pharmacol. 2024. PMID: 39309010 Free PMC article.
Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer?
Foffano L, Vida R, Piacentini A, Molteni E, Cucciniello L, Da Ros L, Silvia B, Cereser L, Roncato R, Gerratana L, Puglisi F. Foffano L, et al. Among authors: gerratana l. Expert Rev Anticancer Ther. 2024 Aug;24(8):679-691. doi: 10.1080/14737140.2024.2362173. Epub 2024 Jul 1. Expert Rev Anticancer Ther. 2024. PMID: 38855809 Review.
Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNA.
Zhang Q, Cai Z, Gerratana L, Davis AA, D'Amico P, Chawla A, Jacob S, Zhang Y, Jiao J, Qin W, Reduzzi C, Flaum L, Shah A, Gradishar WJ. Zhang Q, et al. Among authors: gerratana l. Clin Cancer Res. 2024 Aug 15;30(16):3470-3480. doi: 10.1158/1078-0432.CCR-24-0535. Clin Cancer Res. 2024. PMID: 38829582
106 results